Previous studies showed that the expression of SNAT2 was increased in ER+ breast cancer cell lines after 17β-estradiol (E2) stimulation, and an estrogen response element was described in the SNAT2 promoter in rat mammary glands during gestation (22, 23). This evidence concerns the gene ESR1 and breast carcinoma.